In studies, the Galleri test has shown the ability to detect multiple types of cancers through a single blood draw. Most of these cancers cannot be detected through current screening paradigms. When cancer signal was detected, the Galleri test localized the cancer signal with high accuracy, helping inform next steps to diagnosis.1
The Galleri test is intended to be complementary to, and not a replacement of, U.S. guideline-recommended cancer screening.
Galleri is a trademark of GRAIL, Inc.